Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Researchers’ discovery may lead to better antifungal drugs
Researchers led by Dr Mira Edgerton, discovered that histatin binds to a specific membrane protein called TRK1p, which regulates potassium ion flow through the cell membrane of the
Researchers led by Dr Mira Edgerton, discovered that histatin binds to a specific membrane protein called TRK1p, which regulates potassium ion flow through the cell membrane of the
Sepracor’s Xopenex (levalbuterol tartrate) metered-dose inhaler (MDI) utilizes state-of-the-art HFA technology and does not contain a CFC propellant. Sepracor and 3M’s drug delivery systems division are collaborating under
The trial, named AX-CL-06a, is designed to evaluate the effects of Phenserine tartrate (PT) on cerebrospinal fluid (CSF) levels of beta-amyloid (A(beta) 1- 42) and other biomarkers in
Baraclude (entecavir) is an investigational oral antiviral agent that selectively inhibits the hepatitis B virus. Bristol-Myers Squibb submitted a new drug application (NDA) to the FDA for Baraclude
Sanofi-Aventis learned through the Canadian Ministry of Health website that Novopharm has obtained marketing approval in Canada for a product claiming to be generic enoxaparin. Sanofi-Aventis companies Aventis
The National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), approved the collaboration with Adherex following their formal review of existing preclinical and
The trial was designed to test the safety and analgesic efficacy of Prosaptide in HIV/AIDS patients with peripheral neuropathic pain. Following a formal interim analysis, the Data and
These results are from the largest, most comprehensive study ever done comparing the effectiveness of hand hygiene products, and reported by researchers at the University of North Carolina
Under the 18-month contract, Xoma will produce three botulinum neurotoxin monoclonal antibodies designed to protect US citizens against the harmful effects of biological agents used in bioterrorism. Xoma
The Academy, the largest of all dermatologic associations, said that it was disappointed with the FDA’s action and that there is no data to prove that proper topical